REGENXBIO
RGNX
NZ$14.11
Share price
-4.32%
Change (1 day)
-41.96%
Change (1 year)
Categories
REGENXBIO (RGNX) - Total liabilities
Total liabilities on the balance sheet as of March 2025 : NZ$0.36 Billion
According to REGENXBIO's latest financial reports the company's total liabilities are NZ$0.36 Billion. A company’s total liabilities is the sum of all current and non-current debts and obligations.
REGENXBIO - Total liabilities on balance sheet (from 2014 to 2025)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2024-12-31 | NZ$0.36 B | -11.77% |
| 2023-12-31 | NZ$0.41 B | -16.97% |
| 2022-12-31 | NZ$0.49 B | -2.43% |
| 2021-12-31 | NZ$0.51 B | 11.77% |
| 2020-12-31 | NZ$0.45 B | 546.4% |
| 2019-12-31 | NZ$70.84 M | 35.9% |
| 2018-12-31 | NZ$52.12 M | 136.59% |
| 2017-12-31 | NZ$22.03 M | 38.81% |
| 2016-12-31 | NZ$15.87 M | 137.61% |
| 2015-12-31 | NZ$6.68 M | -43.04% |
| 2014-12-31 | NZ$11.72 M | 107.13% |
| 2013-12-31 | NZ$5.66 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | NZ$38.79 M | -89.33% | 🇺🇸 USA |